Walvax Biotechnology Co., Ltd. (300142) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Walvax Biotechnology Co., Ltd.

Why is Walvax Biotechnology Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 4.90% and Operating profit at -189.43% over the last 5 years

The company has declared negative results for the last 7 consecutive quarters

OPERATING CASH FLOW(Y) Lowest at CNY 560.33 MM
ROCE(HY) Lowest at 0.51%
DEBTORS TURNOVER RATIO(HY) Lowest at 0.93 times

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 4.28%, its profits have fallen by -121.8%
At the current price, the company has a high dividend yield of 0.1

Underperformed the market in the last 1 year

The stock has generated a return of 4.28% in the last 1 year, much lower than market (China Shanghai Composite) returns of 15.17%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Walvax Biotechnology Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Walvax Biotechnology Co., Ltd.

3.04%

-0.08

39.00%

China Shanghai Composite

15.17%

1.02

14.86%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

4.90%

EBIT Growth (5y)

-189.43%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.32

Sales to Capital Employed (avg)

0.34

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

11.25%

Pledged Shares

Institutional Holding

ROCE (avg)

13.84%

ROE (avg)

9.19%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.93

EV to EBIT

-79.27

EV to EBITDA

72.58

EV to Capital Employed

2.24

EV to Sales

6.33

PEG Ratio

Dividend Yield

0.09%

ROCE (Latest)

-2.83%

ROE (Latest)

-1.13%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bullish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -7.02% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 1.02 times

EPS(Q)

Highest at CNY 0.08

-31What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 560.33 MM

ROCE(HY)

Lowest at 0.51%

DEBTORS TURNOVER RATIO(HY)

Lowest at 0.93 times

NET SALES(Q)

At CNY 564.6 MM has Fallen at -19.76%

PRE-TAX PROFIT(Q)

At CNY 46.03 MM has Fallen at -47.51%

DEBT-EQUITY RATIO (HY)

Highest at -14.55 %

INTEREST(Q)

Highest at CNY 2.53 MM

NET PROFIT(Q)

Fallen at -35.05%

Here's what is working for Walvax Biotechnology Co., Ltd.

EPS

Highest at CNY 0.08

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Inventory Turnover Ratio

Highest at 1.02 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -7.02% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Walvax Biotechnology Co., Ltd.

Operating Cash Flow

Lowest at CNY 560.33 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

At CNY 564.6 MM has Fallen at -19.76%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Interest

At CNY 2.53 MM has Grown at 377.05%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Pre-Tax Profit

At CNY 46.03 MM has Fallen at -47.51%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Debtors Turnover Ratio

Lowest at 0.93 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Interest

Highest at CNY 2.53 MM

in the last five periods and Increased by 377.05% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Profit

Fallen at -35.05%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Debt-Equity Ratio

Highest at -14.55 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio